AstraZeneca's FluMist nasal spray vaccine approved for self-administration
FluMist, which was initially approved in 2023, is indicated for individuals from two to 49 years old. Those who want to ...
Time12d
An At-Home Nasal Vaccine
The FDA recently approved the first at-home vaccine to prevent influenza, the nasal spray FluMist, which was originally ... the spray for children.) AstraZeneca expects to have doses ready for ...
FDA approves first self-administered flu vaccine spray
The FluMist vaccine, manufactured by AstraZeneca, had previously been approved back in 2003 to be given by health care ...
Nasdaq1mon
FLUMIST approved for self-administration in the US
1 Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
Baylor College of Medicine20d
FluMist: Who is the nasal spray best for?
FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...
WSAZ1mon
FDA approves nasal mist flu vaccine
The FDA has approved AstraZeneca’s FluMist Nasal Spray to be used outside a healthcare setting. “The new FDA release is for FluMist. It is a live attenuated vaccine, it actually has been ...
Yahoo1mon
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first ...
Yahoo1mon
FDA approves at-home flu vaccine nasal spray. Here's what to know about it.
FluMist was produced by the AstraZeneca company. The FDA stated in a release on Friday, "FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in ...
London South East1mon
AstraZeneca gets FDA approval for FluMist self-administration
(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. The Cambridge, England-based biopharmaceutical company ...
Investing1mon
AstraZeneca's FluMist now US-approved for home use
AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) has received approval from the US Food and Drug Administration (FDA) for its FluMist influenza vaccine to be self-administered, marking a significant shift in ...
WGNO1mon
FDA approves first self-administered flu vaccine
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...